Active ingredientGrapiprantCat. No. P-G060-001CAS 415903-37-6Family · Pharmaceutical analytical standards
Grapiprant
A prostaglandin E2 EP4 receptor antagonist, approved in the United States in 2016 as a veterinary medicine for the pain and inflammation of osteoarthritis in dogs. This family brings together the active ingredient and other impurities.
Did you know?Unlike classic NSAIDs it does not block the cyclooxygenases: of the four prostaglandin E2 receptors it switches off just one, EP4, which carries much of the pain signal.
Go to the active ingredient →Active ingredientGrapiprantCat. No. P-G060-001CAS 415903-37-6
ImpurityGrapiprant Impurity 1Cat. No. P-G060-002CAS 415908-96-2
ImpurityGrapiprant Carbamic Acid ImpurityCat. No. P-G060-003CAS 415905-93-0
ImpurityGrapiprant Impurity 1 HCl SaltCat. No. P-G060-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.